newsfilter
← Latest News
GlobeNewswire·

PLx Pharma Inc. Reports Second Quarter 2022 Results and Provides Business Update

- Initiates Evaluation of Strategic Alternatives to Enhance Stockholder Value - Reports Positive Results of VAZALORE® 81 mg Patient Experience Survey - Streamlines Sales & Marketing Plan Total Net Sales of $0.5 Million, Including $0.4 Million